By Scott Gottlieb (Original source Fierce Biotech)
“Scott Gottlieb’s relatively short two-year tenure as the FDA’s head has ended, and we have a new man at the helm: Ned Sharpless. However, he used his first official talk to ensure we all know he’s not looking to tear up Gottlieb’s legacy.
Gottlieb, in fact, denied to reporters at the start of the year that he was leaving, but a few short months later he announced he was doing exactly that (citing commuting times), and then preceded to have the world’s longest goodbye tour. Fitting, I suppose, for a rock’n’roll FDA commissioner.
Gottlieb was praised by many in the bio Twitter sphere, as well as by President Donald Trump, the man who appointed him as FDA commissioner. Some areas, though, namely the opioid crisis and the surge in an anti-vaxxer movement, which has also seen a related spike in measles cases in the U.S., are still areas the FDA must get a grip on.”
Anderson Cooper brings you highlights from CNN’s premier nightly news program AC360. At least 24 people have died in the wildfires that have ravaged Los Angeles County, and…
Newt talks with Dr. Weifeng Zhong, about the significant cybersecurity breach involving the US Treasury Department, where a hacker accessed security keys to override protocols…
On January 13, 2025, the Animal and Plant Health Inspection Service (APHIS), part of the United States Department of Agriculture (USDA), announced that it has…